Systemic therapy for cutaneous T-cell lymphoma: who, when, what, and why?

CTCL are rare neoplasms. Optimal care requires integrated use of diagnostic and treatment modalities spanning multiple specialties. Current instruments for patient risk stratification and disease measurement across all anatomical compartments are suboptimal.